# Wonju Severance Christian Hospital

Organization · id `cardio:org-wonju-severance-christian-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 01b346b72](<https://ror.org/01b346b72>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 01b346b72 by an exact name.

## The registry's words

- Sponsor name: Wonju Severance Christian Hospital
- Sponsor class: OTHER
- ROR name: Wonju Severance Christian Hospital

## Connected pages

- Sponsors: A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension (`cardio:ct-nct01518998`)
- Sponsors: Comparision of Blood Pressure Variability Between Amlodipine and Losartan (`cardio:ct-nct01964079`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)
- Sponsors: Comparison of Biomatrix and Orsiro Drug Eluting Stent (`cardio:ct-nct02299011`)
- Sponsors: FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease (`cardio:ct-nct02715518`)
- Sponsors: Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (`cardio:ct-nct04014803`)
- Sponsors: Long-term Beta-blocker Therapy After Acute Myocardial Infarction (`cardio:ct-nct04769362`)
- Sponsors: Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors (`cardio:ct-nct04921189`)
- Sponsors: Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia (`cardio:ct-nct06250712`)
- Sponsors: Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy (`cardio:ct-nct07796217`)

## Provenance

Content hash: 817af89fa50cf5435c8be7b122568ec62597d247869b44e24d6a083f8f73fc57
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
